News

CIMR experts comment on a major advance in protein research

2 December 2020

There has been wide interest in AlphaFold2, a program from Google’s DeepMind Artificial Intelligence (AI) network which was reported as having solved a long-standing challenge in biology. The incredible range of different behaviour and functions found across proteins depends upon their 3D structures - in turn, largely...

CIMR Principal Investigator recognised as 'highly-cited researcher' in 2020

19 November 2020

Professor David Rubinsztein FRS has been highlighted by the Web of Science Group as a 2020 ‘Highly Cited Researcher’ for his research on mechanisms of autophagy and neurodegeneration. This reflects analysis by Web of Science of Prof. Rubinsztein’s research publications in the years 2009 – 2019, many of which rank in the...

Royal Society Dorothy Hodgkin Research Fellowship for CIMR early-career researcher

1 October 2020

Congratulations to Dr Janin Lautenschlaeger, who will start as Royal Society Dorothy Hodgkin Research Fellow at CIMR. Her project, entitled ‘Liquid-liquid phase separation of alpha-synuclein at the presynaptic terminal’ will be carried out in Prof. Peter St George-Hyslop’s lab and focus on the recently-discovered property...

Award for rare disease research at CIMR

25 September 2020

Congratulations to Dr Joseph Chambers of the Marciniak Lab, one of two winners of the 18th Annual Alpha-1-Antitrypsin Laurell’s Training Award. This global award is to support early-career researchers working on alpha-1-antitrypsin deficiency. Joseph’s project is entitled ‘Effects of alpha-1 antitrypsin polymerisation on...

CIMR spin-out company starts first clinical trial

19 August 2020

Z Factor Ltd have announced that dosing has begun in a Phase I study of ZF874, their first-in-class, small molecule drug. This was discovered from research at Prof. Jim Huntington's laboratory in CIMR as a potential treatment for alpha-1-antitrypsin deficiency (AATD). Most forms of this genetic disease are caused by the...

New Wellcome Trust Fellowship award at CIMR

13 July 2020

Congratulations to Dr Chloe Johnson for being awarded a Sir Henry Wellcome Postdoctoral Fellowship at the CIMR. With Professor Folma Buss, Chloe will be investigating the spatial and temporal regulation of immune-specific myosin motors. In collaboration with Ludwig Maximilian University of Munich and University of Kent...

Senior Academic Promotion

13 July 2020

Congratulations to CIMR Principal Investigator Dr Mike Weekes on his promotion to University Reader.

New Wellcome Trust Fellowship award at CIMR

9 June 2020

We are pleased to welcome Dr Anna Helena Lippert as Sir Henry Wellcome Postdoctoral Fellow at the CIMR.

Published commentary on haemoglobin and COVID-19.

5 May 2020

There was some recent interest in a preprint article which used computer modelling (but no experimental data) to propose that the COVID-19 virus ‘attacks’ haemoglobin in the blood of patients. The preprint has been the basis for claims that COVID-19 is not actually a lung disease. In response, the CIMR’s Prof. Randy Read...

Professor Michael Wakelam 1955-2020

31 March 2020

We were shocked and saddened by the loss of Michael Wakelam following a suspected COVID-19 infection. Michael was a renowned scientist and a kind, thoughtful and inspiring colleague. In addition to his Director’s role at Babraham, Michael held an Honorary Professorship at the University of Cambridge Clinical School, and...

CIMR experts comment on a major advance in protein research

CIMR Principal Investigator recognised as 'highly-cited researcher' in 2020

Royal Society Dorothy Hodgkin Research Fellowship for CIMR early-career researcher

Award for rare disease research at CIMR

CIMR spin-out company starts first clinical trial

New Wellcome Trust Fellowship award at CIMR

Senior Academic Promotion

New Wellcome Trust Fellowship award at CIMR

Published commentary on haemoglobin and COVID-19.

Professor Michael Wakelam 1955-2020

Study at Cambridge

About the University

Research at Cambridge